Earnings at midpoint of guidance. Reduction in working capital and debt. Clear priorities for improved returns and growth.

Highlights

  • Underlying EBITDA $313 million, at the midpoint of guidance.
  • Statutory net loss after tax of $6 million.
  • Net debt 25% below prior year.
  • Net leverage 2.0 times underlying EBITDA.
  • Strong performance from new product introductions1 (NPIs).
  • $50 million omega-3 revenue.
  • Expansion of plantings and improved omega-3 profile from 2024 crop.
  • Expansion of carinata plantings and favorable regulatory developments.

Click here for to view the full ASX Release and Financial Results.